Search Results - "HOCHKEPPEL, H. K"

Refine Results
  1. 1

    MxA Gene Expression after Live Virus Vaccination: A Sensitive Marker for Endogenous Type I Interferon by Roers, A., Hochkeppel, H. K., Horisberger, M. A., Hovanessian, A., Haller, O.

    Published in The Journal of infectious diseases (01-04-1994)
    “…MxA gene expression is known to be regulated tightly and exclusively by type I interferons (IFNs). The kinetics of MxA gene expression was analyzed in…”
    Get full text
    Journal Article
  2. 2

    Identification of novel mdm2 binding peptides by phage display by Böttger, V, Böttger, A, Howard, S F, Picksley, S M, Chène, P, Garcia-Echeverria, C, Hochkeppel, H K, Lane, D P

    Published in Oncogene (21-11-1996)
    “…The oncogene mdm2 and its human homologue hdm2 bind to the tumour suppressor protein p53 and inactivate its function as a transcription factor. This has been…”
    Get more information
    Journal Article
  3. 3

    The human intracellular Mx-homologous protein is specifically induced by type I interferons by von Wussow, P, Jakschies, D, Hochkeppel, H K, Fibich, C, Penner, L, Deicher, H

    Published in European journal of immunology (01-09-1990)
    “…The murine Mx-1 protein is one of the best biochemically and functionally characterized interferon (IFN)-induced proteins that is necessary, and sufficient,…”
    Get more information
    Journal Article
  4. 4

    9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections by GANGEMI, J. D, COZENS, R. M, DE CLERCQ, E, BALZARINI, J, HOCHKEPPEL, H.-K

    Published in Antimicrobial Agents and Chemotherapy (01-11-1989)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5

    Effective Natural Interferon-α Therapy in Recombinant Interferon-α-Resistant Patients With Hairy Cell Leukemia by Wussow, P. von, Pralle, H., Hochkeppel, H.-K., Jakschies, D., Sonnen, S., Schmidt, H., Miiller-Rosenau, D., Franke, M., Haferlach, T., Zwingers, T., Rapp, U., Deicher, H.

    Published in Blood (01-07-1991)
    “…To explore the relationship between anti-interferon-α (anti-IFN-α) antibodies and loss of clinical responsiveness to IFN-α treatment, we examined sera from 59…”
    Get full text
    Journal Article
  6. 6

    IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression by Johnson, J A, Hochkeppel, H K, Gangemi, J D

    Published in Journal of interferon & cytokine research (01-10-1999)
    “…The effects of interferon-tau (IFN-tau) on tumor suppressor factors and virus oncoprotein expression were compared with two other type I IFN in human…”
    Get more information
    Journal Article
  7. 7

    Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8 by HOCHKEPPEL, H. K, BRAUN, D. G, VISCHER, W, IMM, A, SUTTER, S, STAEUBLI, U, GUGGENHEIM, R, KAPLAN, E. L, BOUTONNIER, A, FOURNIER, J. M

    Published in Journal of Clinical Microbiology (01-03-1987)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  8. 8

    Molecular characterization of the hdm2-p53 interaction by Böttger, A, Böttger, V, Garcia-Echeverria, C, Chène, P, Hochkeppel, H K, Sampson, W, Ang, K, Howard, S F, Picksley, S M, Lane, D P

    Published in Journal of molecular biology (27-06-1997)
    “…A number of viral oncogenes target the tumour suppressor protein p53 and inactivate its function. This is an important step in tumourogenesis. The cellular…”
    Get full text
    Journal Article
  9. 9

    Predominance of capsular polysaccharide type 5 among oxacillin-resistant Staphylococcus aureus by FOURNIER, J. M, BOUVET, A, BOUTONNIER, A, AUDURIER, A, GOLDSTEIN, F, PIERRE, J, BURE, A, LEBRUN, L, HOCHKEPPEL, H. K

    Published in Journal of Clinical Microbiology (01-10-1987)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  10. 10
  11. 11

    An interferon-induced mouse protein involved in the mechanism of resistance to influenza viruses. Its purification to homogeneity and characterization by polyclonal antibodies by Horisberger, M A, Hochkeppel, H K

    Published in The Journal of biological chemistry (10-02-1985)
    “…Interferon-alpha + beta (IFN-alpha + beta) plays a central role in the specific resistance to influenza virus infection of those mice carrying the gene Mx (for…”
    Get full text
    Journal Article
  12. 12

    IFN-alpha induced human 78 kD protein: purification and homologies with the mouse Mx protein, production of monoclonal antibodies, and potentiation effect of IFN-gamma by Horisberger, M A, Hochkeppel, H K

    Published in Journal of interferon research (01-08-1987)
    “…A 78-kD protein (p78) is induced in human cells in response to interferon (IFN). It appeared as a radioactive spot when newly synthesized proteins from…”
    Get more information
    Journal Article
  13. 13

    Monoclonal antibody against human IFN- γ by Hochkeppel, H. K, de Ley, M

    Published in Nature (London) (18-03-1982)
    “…Since the discovery that mouse spleen B lymphocytes can be fused with mouse B-myeloma cells to yield hybrid cells (hybridomas) secreting specific antibodies…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Antiviral activity of a novel recombinant human interferon-alpha B/D hybrid by Gangemi, J D, Lazdins, J, Dietrich, F M, Matter, A, Poncioni, B, Hochkeppel, H K

    Published in Journal of interferon research (01-04-1989)
    “…The antiviral potential of a novel cross-species active, recombinant human interferon-alpha B/D hybrid (rHuIFN-alpha B/D), was evaluated for its efficiacy in…”
    Get more information
    Journal Article
  16. 16

    Correlation of the Antiproliferative Effect and the Mx-Homologous Protein Induction by IFN in Patients with Malignant Melanoma by Jakschies, Detlef, Hochkeppel, Heinz-Kurt, Horisberger, Michel Andre, Deicher, Helmuth, Wussow, Peter Von

    Published in Journal of investigative dermatology (01-12-1990)
    “…The human interferon-induced intracellular protein homologous to the murine Mx-protein has recently been identified by means of a specific monoclonal antibody…”
    Get full text
    Journal Article Conference Proceeding
  17. 17

    Biological activities of human recombinant interferon α/β targeted by anti-Epstein-Barr virus monoclonal antibodies by Miescher-Granger, S., Hochkeppel, H.K., Braun, D.G., Alkan, S.S.

    Published in FEBS letters (1985)
    “…The requirement of high doses of interferon (IFN) during therapy severely restrict its application. Thus a model using an Epstein-Barr virus (EBV) membrane…”
    Get full text
    Journal Article
  18. 18

    Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C by Jakschies, D, Zachoval, R, Müller, R, Manns, M, Nolte, K U, Hochkeppel, H K, Horisberger, M A, Deicher, H, Von Wussow, P

    Published in Hepatology (Baltimore, Md.) (01-04-1994)
    “…The human MxA protein is a new specific marker for type I interferon activity both in vitro and in vivo. In the study presented here, this interferon-induced…”
    Get more information
    Journal Article
  19. 19

    Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections by Gangemi, J D, Matter, A, Poncioni, B, Hochkeppel, H K

    Published in Journal of interferon research (01-06-1989)
    “…Treatment of mice infected with Rauscher (RMLV) or Friend (FMLV) murine leukemia viruses at an early stage of disease (beginning at day 0 and continuing every…”
    Get more information
    Journal Article
  20. 20